Asia
Neurocrine Biosciences is partnering with Japan’s Takeda Pharmaceutical to develop and commercialize molecules in Takeda’s early-to-mid-stage psychiatry pipeline.
Sinovac Biotech announced positive early data from a Phase I/II clinical trial of its COVID-19 vaccine, CoronaVac. The vaccine showed both favorable immunogenicity and safety.
BioSpace takes a look at some of the most recent IPO plans from companies across the globe.
It was a fairly busy week with clinical trial updates and announcements. Here’s a look.
Biotech companies expand their footprint and capabilities in a COVID-19 world.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 12, 2020.
With this capital investment, the site will be able to double its current drug substance manufacturing capacity and enhance its existing assembly operations. Production lines for bulk drug substance will be expanded, and development will begin on a new fill/finish production line.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
Charles Lieber, the former chair of Harvard University’s Chemical Biology Department, was indicted by a federal grand jury this week on two counts of making false statements.
Michael Yu, chairman and chief executive officer of Innovent Biologics, said the deal with Roche will help the company continue to move forward in the cellular therapy space.
PRESS RELEASES